Results 181 to 190 of about 935,031 (288)

What do we know about nephrotoxicity of NSAIDs in horses?

open access: yes
Equine Veterinary Education, EarlyView.
C. Di Donato, G. van Galen
wiley   +1 more source

N‐methyl‐D‐aspartate receptor antagonists for controlling pain in dogs

open access: yesJournal of Small Animal Practice, EarlyView.
This is a mini review published by the World Small Animal Veterinary Association's Pain Committee. This article provides an assessment of the scientific evidence of N‐methyl‐d‐aspartate receptor antagonists for controlling pain in dogs while identifying current knowledge gaps.
P. W. Kronen   +6 more
wiley   +1 more source

Neural Pathways for Top-Down Control of Pain During Placebo-Like Analgesia.

open access: yes
Cognitive pain modulation holds promise as the basis of pain therapies that do not rely on opioid analgesics. In placebo analgesia, prior experience and expectations lead to pain suppression in response to the administration of an inert substance ...
Livrizzi, Giulia
core  

Lack of Efficacy of Low‐Dose Cyclobenzaprine on Electromyographic Activity Related to Sleep Bruxism: A Randomized Crossover Double‐Blind Placebo‐Controlled Clinical Trial

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Sleep bruxism (SB) is a motor activity characterized by repetitive masticatory muscle contractions during sleep, commonly associated with tooth damage and jaw pain or headache. Pharmacological management strategies targeting its central nervous system‐related mechanisms remain limited.
Matheus Herreira‐Ferreira   +6 more
wiley   +1 more source

Editorial: Placebo Effect in Pain and Pain Treatment

open access: yesFrontiers in Pain Research, 2022
Michael H. Bernstein   +2 more
doaj   +1 more source

The Endocannabinoid System’s Contribution to Placebo Analgesia

open access: yes
ABSTRACT Placebo analgesia—pain reduction from inert treatments—varies widely across individuals, yet its neurochemical basis remains poorly understood. While endogenous opioids, specifically β-endorphin, contribute to placebo effects, mu-opioid receptor blockade does not fully abolish analgesia, implicating additional systems. Here, we
Rossi Tomin   +9 more
openaire   +2 more sources

Pharmacokinetics of Buccally Administered Cannabidiol and Oral Carprofen During Single‐ and Repeated‐Dose Administration in Dogs

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Cannabidiol (CBD) is increasingly used as an adjunct treatment for chronic pain in dogs, but information on repeated‐dose pharmacokinetics and potential interactions with commonly used analgesics remains limited. This study evaluated the pharmacokinetics of buccally administered CBD, its major metabolites, and orally administered carprofen in ...
Tilen Vake   +9 more
wiley   +1 more source

Top-down control of the descending pain modulatory system drives multimodal placebo analgesia. [PDF]

open access: yesNeuron
Livrizzi G   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy